search
Back to results

Repetitive dTMS Intervention for Methamphetamine Addiction

Primary Purpose

Methamphetamine-dependence

Status
Active
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
real coil
sham coil
Sponsored by
Shanghai Mental Health Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Methamphetamine-dependence focused on measuring deep transcranial magnetic stimulation, methamphetamine addiction

Eligibility Criteria

18 Years - 60 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Methamphetamine dependents
  • middle school degree or above

Exclusion Criteria:

  • Have contraindications to rTMS (head trauma, epilepsy or history of epilepsy, metal implant etc.)
  • psychiatric illnesses
  • intellectual impairment (IQ<90)

Sites / Locations

  • Nanjing Dalianshan Addiction Rehab Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Sham Comparator

Arm Label

10hz group

sham group

Arm Description

a high frequency stimulation

a sham coil which frequency is 10hz but do not induce stimulation

Outcomes

Primary Outcome Measures

Changes of Cue-induced craving and ERP
Subjective craving (cue induced, 0-100 based VAS, craving scale) and drug cue-ERP (P300 etc. measured)

Secondary Outcome Measures

Changes of cognition: behavioral inhibition
using cognitive tasks: stop-signal task
Changes of cognition: working memory
using cognitive tasks: n-back task
Changes of depression status
depression (Beck Depression inventory scale), high score means worse depression
Changes of anxiety status
Anxiety (Beck anxiety inventory scale), higher score means worse anxiety
Changes of sleep status
sleep status measurements (Pittsburgh Sleep Quality Index scale), higher score means worse sleep
Changes of impulsivity
Impulsivity scale (The Barratt Impulsiveness Scale), higher score means higher impulsivity
Changes of resting EEG network
resting EEG signal (Alpha, Beta, Theta, etc) measurement with 128 Channel EGI system

Full Information

First Posted
November 30, 2019
Last Updated
October 26, 2022
Sponsor
Shanghai Mental Health Center
search

1. Study Identification

Unique Protocol Identification Number
NCT04202926
Brief Title
Repetitive dTMS Intervention for Methamphetamine Addiction
Official Title
Repetitive dTMS Intervention for Methamphetamine Addiction
Study Type
Interventional

2. Study Status

Record Verification Date
September 2022
Overall Recruitment Status
Active, not recruiting
Study Start Date
December 30, 2019 (Actual)
Primary Completion Date
December 30, 2023 (Anticipated)
Study Completion Date
December 30, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Shanghai Mental Health Center

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
A growing body of evidence suggests a wide range of brain areas including medial prefrontal cortex (mPFC), dorsolateral prefrontal cortex (DLPFC) and other subcortical regions, such as anterior cingulate cortex (ACC) are critical for regulating cognitive control over decisions and involving in drug related cue processing. Previous studies have demonstrated that transcranial magnetic stimulation (rTMS) over dorsolateral prefrontal cortex reduces craving for meth dependences. Specifically, the H7 coil induces a magnetic field can target mPFC and ACC. In this study, the investigators investigated whether repeated dTMS intervention of medial prefrontal and cingulate cortices in methamphetamine addiction could reduce the subjective craving and improve the cognitive abilities.
Detailed Description
The study will be conducted at the drug rehabilitation center in China. The whole procedure includes enrollment, pre-intervention evaluation, intervention (for 3 weeks, 5 times a week, 15 times in total), post-intervention evaluation and one month follow up evaluation. In enrollment session, participants are recruited according to inclusion criteria. In the pre-intervention evaluation, firstly, participants need complete a questionnaire to assess their demographic information, drug addiction history and drug abstinence. And then are assigned to either 10Hz group or sham group according to the counterbalance of their basic demographic and drug use information. Then, participants need complete craving, cognitive ability and electroencephalogram (EEG) assessment. For craving assessing, participants are shown a video of methamphetamine usage for 5 minutes, and then rated on the visual analogue scale (0 means completely undesired and 100 means extremely wanting) to report their craving for methamphetamine. For cognitive ability and EEG signal assessing, the whole process is conducted on the computer according to instructions. In the intervention session, dTMS was administered using a TMS stimulator (Magstim, U.K.) equipped with a unique H-shaped coil design. The H-coil version used in this study was the H7 (Brainsway, Jerusalem, Israel). When placed 4-5 cm anterior to the foot motor cortex and used at 100% of the leg resting motor threshold (RMT), the H7 coil stimulates the dorsal mPFC and ACC bilaterally. A participant's RMT was determined before the first treatment and at the beginning of each week by ascertaining the coil position that elicited the minimal involuntary contractions of the feet (three of six attempts). The 10Hz group received 10 Hz dTMS at 100% of RMT, with 3-second pulse and 17-second intervals, for a total of 50 trains and 1500 pulses per session. The sham group received treatment with identical technical parameters, which induced scalp sensations but without penetration of the electric field into the brain. Post-intervention evaluation and one month follow up evaluation are the same as in pre-intervention evaluation. To ensure study quality, some measures are taken as bellow: Researchers and drug rehabilitation staff will work together in whole process and the data will be converted into electronic versions once finishing each evaluation. In the intervention, patients, operators, and raters were blind to treatment condition. Each patient is assigned a magnetic card that determined the coil (real or sham) in the helmet and raters are not present while treatments are administered. After each treatment times, any side effect from participant's report are recorded to assure the safety and feasibility. Statistical analyses are performed using SPSS 21.0. The principal statistical analysis is performed using repeated-measures analysis of variance and regression analysis. All missing data will be recorded and marked.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Methamphetamine-dependence
Keywords
deep transcranial magnetic stimulation, methamphetamine addiction

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
60 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
10hz group
Arm Type
Experimental
Arm Description
a high frequency stimulation
Arm Title
sham group
Arm Type
Sham Comparator
Arm Description
a sham coil which frequency is 10hz but do not induce stimulation
Intervention Type
Device
Intervention Name(s)
real coil
Intervention Description
active 10Hz with a train of 3s on / 17s off, 50 trains, a total of 1500 pulses
Intervention Type
Device
Intervention Name(s)
sham coil
Intervention Description
sham 10Hz with a train of 3s on / 17s off, 50 trains, a total of 1500 pulses
Primary Outcome Measure Information:
Title
Changes of Cue-induced craving and ERP
Description
Subjective craving (cue induced, 0-100 based VAS, craving scale) and drug cue-ERP (P300 etc. measured)
Time Frame
the day before intervention, 3 weeks after intervention, 1 month after intervention, up to 3 months after intervention
Secondary Outcome Measure Information:
Title
Changes of cognition: behavioral inhibition
Description
using cognitive tasks: stop-signal task
Time Frame
the day before intervention, 3 weeks after intervention, 1 month after intervention, up to 3 months after intervention
Title
Changes of cognition: working memory
Description
using cognitive tasks: n-back task
Time Frame
the day before intervention, 3 weeks after intervention, 1 month after intervention, up to 3 months after intervention
Title
Changes of depression status
Description
depression (Beck Depression inventory scale), high score means worse depression
Time Frame
the day before intervention, 3 weeks after intervention, 1 month after intervention, up to 3 months after intervention
Title
Changes of anxiety status
Description
Anxiety (Beck anxiety inventory scale), higher score means worse anxiety
Time Frame
the day before intervention, 3 weeks after intervention, 1 month after intervention, up to 3 months after intervention
Title
Changes of sleep status
Description
sleep status measurements (Pittsburgh Sleep Quality Index scale), higher score means worse sleep
Time Frame
the day before intervention, 3 weeks after intervention, 1 month after intervention, up to 3 months after intervention
Title
Changes of impulsivity
Description
Impulsivity scale (The Barratt Impulsiveness Scale), higher score means higher impulsivity
Time Frame
the day before intervention, 3 weeks after intervention, 1 month after intervention, up to 3 months after intervention
Title
Changes of resting EEG network
Description
resting EEG signal (Alpha, Beta, Theta, etc) measurement with 128 Channel EGI system
Time Frame
the day before intervention, 3 weeks after intervention, 1 month after intervention, up to 3 months after intervention
Other Pre-specified Outcome Measures:
Title
side effect measurements
Description
Side effect scale, including headache, pricking, sleeplessness etc.
Time Frame
every day after each intervention time for the 3 weeks intervention time period

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Methamphetamine dependents middle school degree or above Exclusion Criteria: Have contraindications to rTMS (head trauma, epilepsy or history of epilepsy, metal implant etc.) psychiatric illnesses intellectual impairment (IQ<90)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Tifei Yuan, PhD
Organizational Affiliation
Shanghai Mental Health Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Nanjing Dalianshan Addiction Rehab Center
City
Nanjing
ZIP/Postal Code
210090
Country
China

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
share all IPD that underlie results in a publication
IPD Sharing Time Frame
Within twelve months after the trial complete
IPD Sharing Access Criteria
share to health care personnel, patients and the general public.
IPD Sharing URL
http://clinicaltrials.gov
Citations:
PubMed Identifier
26995024
Citation
Shen Y, Cao X, Tan T, Shan C, Wang Y, Pan J, He H, Yuan TF. 10-Hz Repetitive Transcranial Magnetic Stimulation of the Left Dorsolateral Prefrontal Cortex Reduces Heroin Cue Craving in Long-Term Addicts. Biol Psychiatry. 2016 Aug 1;80(3):e13-4. doi: 10.1016/j.biopsych.2016.02.006. Epub 2016 Feb 12. No abstract available.
Results Reference
background
PubMed Identifier
26849183
Citation
Dunlop K, Hanlon CA, Downar J. Noninvasive brain stimulation treatments for addiction and major depression. Ann N Y Acad Sci. 2017 Apr;1394(1):31-54. doi: 10.1111/nyas.12985. Epub 2016 Feb 5.
Results Reference
background
PubMed Identifier
31109199
Citation
Carmi L, Tendler A, Bystritsky A, Hollander E, Blumberger DM, Daskalakis J, Ward H, Lapidus K, Goodman W, Casuto L, Feifel D, Barnea-Ygael N, Roth Y, Zangen A, Zohar J. Efficacy and Safety of Deep Transcranial Magnetic Stimulation for Obsessive-Compulsive Disorder: A Prospective Multicenter Randomized Double-Blind Placebo-Controlled Trial. Am J Psychiatry. 2019 Nov 1;176(11):931-938. doi: 10.1176/appi.ajp.2019.18101180. Epub 2019 May 21.
Results Reference
background
PubMed Identifier
30605708
Citation
Liu T, Li Y, Shen Y, Liu X, Yuan TF. Gender does not matter: Add-on repetitive transcranial magnetic stimulation treatment for female methamphetamine dependents. Prog Neuropsychopharmacol Biol Psychiatry. 2019 Jun 8;92:70-75. doi: 10.1016/j.pnpbp.2018.12.018. Epub 2018 Dec 31.
Results Reference
background
PubMed Identifier
28410525
Citation
Su H, Zhong N, Gan H, Wang J, Han H, Chen T, Li X, Ruan X, Zhu Y, Jiang H, Zhao M. High frequency repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex for methamphetamine use disorders: A randomised clinical trial. Drug Alcohol Depend. 2017 Jun 1;175:84-91. doi: 10.1016/j.drugalcdep.2017.01.037. Epub 2017 Mar 29.
Results Reference
background
PubMed Identifier
29134789
Citation
Liu Q, Shen Y, Cao X, Li Y, Chen Y, Yang W, Yuan TF. Either at left or right, both high and low frequency rTMS of dorsolateral prefrontal cortex decreases cue induced craving for methamphetamine. Am J Addict. 2017 Dec;26(8):776-779. doi: 10.1111/ajad.12638. Epub 2017 Nov 14.
Results Reference
background

Learn more about this trial

Repetitive dTMS Intervention for Methamphetamine Addiction

We'll reach out to this number within 24 hrs